Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:eflornithine
|
| gptkbp:approvedBy |
gptkb:Europe
gptkb:United_States |
| gptkbp:ATCCode |
P01CX03
|
| gptkbp:CASNumber |
70356-03-5
|
| gptkbp:chemicalFormula |
C6H12F2N2O2
|
| gptkbp:developedBy |
gptkb:Aventis
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ornidyl
|
| gptkbp:marketedAs |
gptkb:Vaniqa
|
| gptkbp:mechanismOfAction |
ornithine decarboxylase inhibitor
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
gptkb:anemia
diarrhea seizures leukopenia |
| gptkbp:synonym |
gptkb:eflornithine
|
| gptkbp:usedFor |
treatment of African trypanosomiasis
treatment of sleeping sickness |
| gptkbp:bfsParent |
gptkb:eflornithine
|
| gptkbp:bfsLayer |
6
|